{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:03:26Z","timestamp":1790697806631,"version":"4.1.0"},"reference-count":58,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX000347"],"award-info":[{"award-number":["BX000347"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CXC001248"],"award-info":[{"award-number":["CXC001248"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2BX005605"],"award-info":[{"award-number":["IK2BX005605"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6BX004471"],"award-info":[{"award-number":["IK6BX004471"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["Research Development Award VISN 7"],"award-info":[{"award-number":["Research Development Award VISN 7"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["15PRE1372738"],"award-info":[{"award-number":["15PRE1372738"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["25CDA1449142"],"award-info":[{"award-number":["25CDA1449142"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","award":["Empowering Lupus Research Supplement"],"award-info":[{"award-number":["Empowering Lupus Research Supplement"]}],"id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012051","name":"Lupus Research Alliance","doi-asserted-by":"publisher","award":["Lupus Innovation Award - 1308994"],"award-info":[{"award-number":["Lupus Innovation Award - 1308994"]}],"id":[{"id":"10.13039\/100012051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30AR072582"],"award-info":[{"award-number":["P30AR072582"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AR078545"],"award-info":[{"award-number":["R01AR078545"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK126720"],"award-info":[{"award-number":["R01DK126720"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK129227"],"award-info":[{"award-number":["R01DK129227"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R25GM113278"],"award-info":[{"award-number":["R25GM113278"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1NS083559"],"award-info":[{"award-number":["RF1NS083559"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32AR050958"],"award-info":[{"award-number":["T32AR050958"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32GM12055"],"award-info":[{"award-number":["T32GM12055"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,6,13]]},"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      Cardiovascular disease in SLE is not fully explained by traditional risk factors, supporting a role for disease-specific immunovascular mechanisms. Autoantibodies targeting endothelin receptor A (ET\n                      <jats:sub>A<\/jats:sub>\n                      R) and endothelin receptor B (ET\n                      <jats:sub>B<\/jats:sub>\n                      R) have been implicated in vascular injury in other autoimmune diseases, but their clinical and functional relevance in SLE remains unclear. We tested whether ET receptor autoantibodies associate with endothelial activation and directly stimulate ET receptor signalling in SLE.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Plasma anti-ET\n                      <jats:sub>A<\/jats:sub>\n                      R and anti-ET\n                      <jats:sub>B<\/jats:sub>\n                      R autoantibodies and soluble vascular cell adhesion molecule-1 (sVCAM-1) were measured in a pilot cohort of women with SLE and non-SLE controls and in an independent validation cohort stratified by SLE and hypertension (HTN) status. Multivariable models adjusted for demographic variables, blood pressure and medication use. Mechanistic studies were performed in primary human renal endothelial cells (HRECs) using live-cell calcium (Ca\n                      <jats:sup>2+<\/jats:sup>\n                      ) imaging, ET receptor antagonists and receptor-directed blocking peptides.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Anti-ET\n                      <jats:sub>A<\/jats:sub>\n                      R and anti-ET\n                      <jats:sub>B<\/jats:sub>\n                      R autoantibodies were elevated in SLE across both cohorts, with the highest level observed in SLE with HTN. Anti-ET\n                      <jats:sub>A<\/jats:sub>\n                      R demonstrated the strongest association with sVCAM-1 and independently identified women with the highest endothelial activation burden beyond clinical covariates and anti-double-stranded DNA. In primary HRECs, SLE-derived IgG induced Ca\n                      <jats:sup>2+<\/jats:sup>\n                      flux that was attenuated by ET receptor antagonism. Blockade of the ET\n                      <jats:sub>A<\/jats:sub>\n                      R extracellular loop 2 domain reduced IgG-mediated Ca\n                      <jats:sup>2+<\/jats:sup>\n                      signalling, supporting a non-canonical mechanism of endothelial ET\n                      <jats:sub>A<\/jats:sub>\n                      R activation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Anti-ETAR autoantibodies associate with immunovascular risk and endothelial activation in SLE and directly stimulate endothelial signalling through a non-canonical ETAR-dependent mechanism. These findings support the use of anti-ETAR autoantibodies as clinically relevant biomarkers and potential novel contributors to vascular dysfunction in SLE.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2026-002117","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:06:15Z","timestamp":1782914775000},"page":"e002117","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-endothelin receptor A autoantibodies associate with immunovascular risk and activate endothelial signalling in SLE"],"prefix":"10.1136","volume":"13","author":[{"given":"Marice K","family":"McCrorey","sequence":"first","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"},{"name":"Ralph H Johnson VA Health Care System, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Elaine","family":"Zehntner","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Rainone","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marharyta","family":"Semenikhina","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan S","family":"Lacey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Alex","family":"Colvert","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kennedy P","family":"Hawkins","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg","family":"Palygin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasir","family":"Abdul","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adviye","family":"Ergul","sequence":"additional","affiliation":[{"name":"Ralph H Johnson VA Health Care System, Charleston, South Carolina, USA"},{"name":"Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9207-1986","authenticated-orcid":false,"given":"Melissa A","family":"Cunningham","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-1359","authenticated-orcid":false,"given":"Jim C","family":"Oates","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"},{"name":"Medical Service, Ralph H Johnson VA Medical Center, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9265-9915","authenticated-orcid":false,"given":"Justin P","family":"Van Beusecum","sequence":"additional","affiliation":[{"name":"Department of Medicine, Medical University of South Carolina, Charleston, South Carolina, USA"},{"name":"Ralph H Johnson VA Health Care System, Charleston, South Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"2026092908101224000_13.2.e002117.1","doi-asserted-by":"publisher","DOI":"10.1053\/berh.2002.0259"},{"key":"2026092908101224000_13.2.e002117.2","doi-asserted-by":"publisher","DOI":"10.1002\/art.22641"},{"key":"2026092908101224000_13.2.e002117.3","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2478\/rir-2021-0022","article-title":"Cardiovascular disease in systemic lupus erythematosus","volume":"2","author":"McMahon","year":"2021","journal-title":"Rheumatol Immunol Res"},{"key":"2026092908101224000_13.2.e002117.4","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001152","article-title":"Cardiovascular risk factors and complications in patients with systemic lupus erythematosus with and without nephritis: a systematic review and meta-analysis","volume":"11","author":"Wong","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2026092908101224000_13.2.e002117.5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-51546-1","article-title":"Increased cardiovascular risk in Korean patients with systemic lupus erythematosus: a population-based cohort study","volume":"14","author":"Han","year":"2024","journal-title":"Sci Rep"},{"key":"2026092908101224000_13.2.e002117.6","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000681","article-title":"Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus","volume":"9","author":"Fasano","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2026092908101224000_13.2.e002117.7","first-page":"2133","article-title":"Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission","volume":"30","author":"Wais","year":"2003","journal-title":"J Rheumatol"},{"key":"2026092908101224000_13.2.e002117.8","first-page":"189","article-title":"Soluble vascular cell adhesion molecule-1 indicates SLE disease activity and specific organ involvement","volume":"54","author":"Pizarro","year":"2007","journal-title":"Rev Alerg Mex"},{"key":"2026092908101224000_13.2.e002117.9","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15761"},{"key":"2026092908101224000_13.2.e002117.10","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.119.14240"},{"key":"2026092908101224000_13.2.e002117.11","doi-asserted-by":"publisher","DOI":"10.7326\/M14-1753"},{"key":"2026092908101224000_13.2.e002117.12","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/acr.23880","article-title":"Increased Incidence of Resistant Hypertension in Patients With Systemic Lupus Erythematosus: A Retrospective Cohort Study","volume":"72","author":"Gandelman","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2026092908101224000_13.2.e002117.13","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1177\/0961203319856988","article-title":"Increased blood pressure visit-to-visit variability in patients with systemic lupus erythematosus: association with inflammation and comorbidity burden","volume":"28","author":"Reese","year":"2019","journal-title":"Lupus"},{"key":"2026092908101224000_13.2.e002117.14","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2802-0"},{"key":"2026092908101224000_13.2.e002117.15","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.25.4.501"},{"key":"2026092908101224000_13.2.e002117.16","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.895501","article-title":"Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension","volume":"13","author":"Tabeling","year":"2022","journal-title":"Front Immunol"},{"key":"2026092908101224000_13.2.e002117.17","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000095980.43859.59"},{"key":"2026092908101224000_13.2.e002117.18","doi-asserted-by":"publisher","DOI":"10.1038\/hr.2014.160"},{"key":"2026092908101224000_13.2.e002117.19","doi-asserted-by":"publisher","DOI":"10.1038\/ajh.2010.125"},{"key":"2026092908101224000_13.2.e002117.20","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1152\/japplphysiol.00816.2019","article-title":"Endothelin-1-induced endothelial microvesicles impair endothelial cell function","volume":"128","author":"Brewster","year":"2020","journal-title":"J Appl Physiol"},{"key":"2026092908101224000_13.2.e002117.21","doi-asserted-by":"crossref","first-page":"15970","DOI":"10.1038\/s41598-023-43350-0","article-title":"Association between endothelin-1 and systemic lupus erythematosus: insights from a case\u2013control study","volume":"13","author":"Li","year":"2023","journal-title":"Sci Rep"},{"key":"2026092908101224000_13.2.e002117.22","first-page":"1307","article-title":"Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus","volume":"35","author":"Kuryliszyn-Moskal","year":"2008","journal-title":"J Rheumatol"},{"key":"2026092908101224000_13.2.e002117.23","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1152\/ajpendo.00274.2022","article-title":"Endothelin receptor antagonism improves glucose tolerance and adipose tissue inflammation in an experimental model of systemic lupus erythematosus","volume":"324","author":"Rivera-Gonzalez","year":"2023","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2026092908101224000_13.2.e002117.24","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ki.1995.61","article-title":"Effect of a specific endothelin A receptor antagonist on murine lupus nephritis","volume":"47","author":"Nakamura","year":"1995","journal-title":"Kidney Int"},{"key":"2026092908101224000_13.2.e002117.25","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacc.2023.10.045","article-title":"Randomized Trial of Macitentan\/Tadalafil Single-Tablet Combination Therapy for Pulmonary Arterial Hypertension","volume":"83","author":"Gr\u00fcnig","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026092908101224000_13.2.e002117.26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02034-7"},{"key":"2026092908101224000_13.2.e002117.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02302-4"},{"key":"2026092908101224000_13.2.e002117.28","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99363","article-title":"Anti-GRP78 autoantibodies induce endothelial cell activation and accelerate the development of atherosclerotic lesions","volume":"3","author":"Crane","year":"2018","journal-title":"JCI Insight"},{"key":"2026092908101224000_13.2.e002117.29","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1002\/art.39212","article-title":"Anti-Endothelin Receptor Type A Autoantibodies in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension","volume":"67","author":"Guo","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026092908101224000_13.2.e002117.30","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201403-0442OC"},{"key":"2026092908101224000_13.2.e002117.31","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-11315-9","article-title":"Factor Xa Mediates Calcium Flux in Endothelial Cells and is Potentiated by Igg From Patients With Lupus and\/or Antiphospholipid Syndrome","volume":"7","author":"Artim-Esen","year":"2017","journal-title":"Sci Rep"},{"key":"2026092908101224000_13.2.e002117.32","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02415","article-title":"Low pH Exposure During Immunoglobulin G Purification Methods Results in Aggregates That Avidly Bind Fc\u03b3 Receptors: Implications for Measuring Fc Dependent Antibody Functions","volume":"10","author":"Lopez","year":"2019","journal-title":"Front Immunol"},{"key":"2026092908101224000_13.2.e002117.33","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1021\/acs.jproteome.4c00268","article-title":"Comparative Analysis of Laboratory-Scale Immunoglobulin G Purification Methods from Human Serum","volume":"23","author":"Bourel","year":"2024","journal-title":"J Proteome Res"},{"key":"2026092908101224000_13.2.e002117.34","doi-asserted-by":"publisher","DOI":"10.1016\/j.preghy.2018.10.002"},{"key":"2026092908101224000_13.2.e002117.35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41581-023-00797-8","article-title":"Vascular damage in systemic lupus erythematosus","volume":"20","author":"Ambler","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"2026092908101224000_13.2.e002117.36","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.974826","article-title":"Immune mechanisms associated with cardiovascular disease in systemic lupus erythematosus: A path to potential biomarkers","volume":"13","author":"Guzm\u00e1n-Mart\u00ednez","year":"2022","journal-title":"Front Immunol"},{"key":"2026092908101224000_13.2.e002117.37","doi-asserted-by":"crossref","first-page":"v29","DOI":"10.1093\/rheumatology\/keaa382","article-title":"Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors","volume":"59","author":"Arnaud","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2026092908101224000_13.2.e002117.38","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00911","article-title":"The Contribution of Autoantibodies to Inflammatory Cardiovascular Pathology","volume":"9","author":"Meier","year":"2018","journal-title":"Front Immunol"},{"key":"2026092908101224000_13.2.e002117.39","doi-asserted-by":"crossref","DOI":"10.1186\/ar4457","article-title":"Autoantibodies to angiotensin and endothelin receptors in systemic sclerosis induce cellular and systemic events associated with disease pathogenesis","volume":"16","author":"Kill","year":"2014","journal-title":"Arthritis Res Ther"},{"key":"2026092908101224000_13.2.e002117.40","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3390\/ijms23010244","article-title":"Autoantibodies Targeting AT1- and ETA-Receptors Link Endothelial Proliferation and Coagulation via Ets-1 Transcription Factor","volume":"23","author":"Catar","year":"2021","journal-title":"IJMS"},{"key":"2026092908101224000_13.2.e002117.41","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.5152\/eurjrheum.2020.19131","article-title":"Putative functional pathogenic autoantibodies in systemic sclerosis","volume":"7","author":"Benfaremo","year":"2020","journal-title":"Eur J Rheumatol"},{"key":"2026092908101224000_13.2.e002117.42","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jcf.2014.07.007","article-title":"Anti-ETAR and anti-AT1R autoantibodies are elevated in patients with endstage cystic fibrosis","volume":"14","author":"Budding","year":"2015","journal-title":"J Cyst Fibros"},{"key":"2026092908101224000_13.2.e002117.43","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.135772"},{"key":"2026092908101224000_13.2.e002117.44","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24961","article-title":"Association between anti-endothelial antigen antibodies and allograft rejection in kidney transplantation","volume":"37","author":"Lee","year":"2023","journal-title":"J Clin Lab Anal"},{"key":"2026092908101224000_13.2.e002117.45","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.ekir.2020.09.004","article-title":"Endothelin Type A Receptor Antibodies Are Associated With Angiotensin II Type 1 Receptor Antibodies, Vascular Inflammation, and Decline in Renal Function in Pediatric Kidney Transplantation","volume":"5","author":"Pearl","year":"2020","journal-title":"Kidney Int Rep"},{"key":"2026092908101224000_13.2.e002117.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2011.01.003"},{"key":"2026092908101224000_13.2.e002117.47","doi-asserted-by":"crossref","first-page":"29036","DOI":"10.1038\/srep29036","article-title":"Role of agonistic autoantibodies against type-1 angiotensin II receptor in the pathogenesis of retinopathy in preeclampsia","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"2026092908101224000_13.2.e002117.48","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/art.43099","article-title":"Absence of Functional Autoantibodies Targeting Angiotensin II Receptor Type 1 and Endothelin-1 Type A Receptor in Circulation and Purified IgG From Patients With Systemic Sclerosis","volume":"77","author":"van Oostveen","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"2026092908101224000_13.2.e002117.49","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.kint.2026.01.014","article-title":"Podocyte-derived endothelin-1 and endothelial cell endothelin A receptors are essential for glomerular injury in mouse models of focal segmental glomerulosclerosis","volume":"109","author":"Yu","year":"2026","journal-title":"Kidney Int"},{"key":"2026092908101224000_13.2.e002117.50","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.ekir.2021.04.013","article-title":"Endothelial Endothelin Receptor A Expression Is Associated With Podocyte Injury and Oxidative Stress in Patients With Focal Segmental Glomerulosclerosis","volume":"6","author":"van de Lest","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2026092908101224000_13.2.e002117.51","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.12105"},{"key":"2026092908101224000_13.2.e002117.52","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.33549\/physiolres.933872","article-title":"New drugs and emerging therapeutic targets in the endothelin signaling pathway and prospects for personalized precision medicine","volume":"67","author":"Davenport","year":"2018","journal-title":"Physiol Res"},{"key":"2026092908101224000_13.2.e002117.53","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-019-0176-3"},{"key":"2026092908101224000_13.2.e002117.54","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23020927","article-title":"Antibodies against Angiotensin II Type 1 and Endothelin 1 Type A Receptors in Cardiovascular Pathologies","volume":"23","author":"Civieri","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026092908101224000_13.2.e002117.55","doi-asserted-by":"publisher","DOI":"10.1291\/hypres.19.201"},{"key":"2026092908101224000_13.2.e002117.56","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033998","article-title":"Angiotensin II Directly Increases Endothelial Calcium and Nitric Oxide in Kidney and Brain Microvessels In Vivo With Reduced Efficacy in Hypertension","volume":"13","author":"Becerra Calderon","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"2026092908101224000_13.2.e002117.57","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00005-022-00660-x","article-title":"Angiotensin II Type 1 Receptor Antibodies Are Higher in Lupus Nephritis and Vasculitis than Other Glomerulonephritis Patients","volume":"70","author":"Szymczak","year":"2022","journal-title":"Arch Immunol Ther Exp"},{"key":"2026092908101224000_13.2.e002117.58","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0961203320904787","article-title":"Angiotensin II receptor agonist antibodies are associated with microvascular damage in lupus nephritis","volume":"29","author":"Mejia-Vilet","year":"2020","journal-title":"Lupus"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2026-002117","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:14:35Z","timestamp":1790694875000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2026-002117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":58,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,7,1]]},"published-print":{"date-parts":[[2026,7]]}},"alternative-id":["10.1136\/lupus-2026-002117"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2026-002117","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7]]}}}